Editorial: The management of hematologic malignancies in lower-income countries

Frontiers in Oncology

Oncology

Reena Nair¹  Mustafa Saleh²  Jean El Cheikh²  Sung-Hsin Kuo³  Alessandro Isidori⁴  Prasanth Ganesan⁵ 

[1] Clinical Haematology Oncology and Hematopoietic Cell Transplantation (HCT), Tata Medical Centre, Kolkata, India;Department of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon;Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan;Hematology and Stem Cell Transplant Center, Marche Norde Hospital, Pesaro, Italy;Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India;

关键词: lower and middle income countries;    hematological malignancies;    allogenic stem cell transplantation;    infectious complication;    survival;   

DOI  :  10.3389/fonc.2023.1218718

 received in 2023-05-08, accepted in 2023-05-15,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Ganesan, El Cheikh, Isidori, Kuo, Saleh and Nair